Normal view MARC view ISBD view

Zhou, Q

Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy. [electronic resource] - Clinical and experimental immunology Jul 2013 - 131-9 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

ISSN: 1365-2249

Standard No.: 10.1111/cei.12095 doi

Subjects--Topical Terms:
Antibodies, Monoclonal, Humanized--pharmacology
Antibodies, Monoclonal, Murine-Derived--pharmacology
Antibody-Dependent Cell Cytotoxicity--drug effects
Antigens, Surface--metabolism
Antineoplastic Agents--pharmacology
CD3 Complex--metabolism
Cell Degranulation--drug effects
Cell Line, Tumor
Cetuximab
Coculture Techniques
Cytokines--blood
Dipeptides--pharmacology
Down-Regulation--drug effects
GPI-Linked Proteins--metabolism
Humans
Killer Cells, Natural--drug effects
Lymphocyte Activation--drug effects
Matrix Metalloproteinase Inhibitors--pharmacology
Matrix Metalloproteinases--physiology
Phosphorylation--drug effects
Protein Processing, Post-Translational--drug effects
Receptors, IgG--metabolism
Rituximab
Signal Transduction--drug effects
Trastuzumab